Annual CFI
$114.29 M
+$99.97 M+697.98%
December 31, 2023
Summary
- As of February 8, 2025, NGM annual cash flow from investing activities is $114.29 million, with the most recent change of +$99.97 million (+697.98%) on December 31, 2023.
- During the last 3 years, NGM annual CFI has risen by +$165.28 million (+324.10%).
Performance
NGM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$27.19 M
+$323.00 K+1.20%
December 31, 2023
Summary
- As of February 8, 2025, NGM quarterly cash flow from investing activities is $27.19 million, with the most recent change of +$323.00 thousand (+1.20%) on December 31, 2023.
- Over the past year, NGM quarterly CFI has dropped by -$8.45 million (-23.71%).
Performance
NGM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$114.29 M
+$25.50 M+28.73%
December 31, 2023
Summary
- As of February 8, 2025, NGM TTM cash flow from investing activities is $114.29 million, with the most recent change of +$25.50 million (+28.73%) on December 31, 2023.
- Over the past year, NGM TTM CFI has increased by +$57.47 million (+101.15%).
Performance
NGM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NGM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +698.0% | -23.7% | +101.2% |
| 3 y3 years | +324.1% | +123.7% | +324.1% |
| 5 y5 years | +195.1% | +680.9% | +134.6% |
NGM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -162.7% | -23.7% | -158.7% | at high | -162.7% |
| 5 y | 5-year | at high | -162.7% | -48.0% | -530.8% | at high | -302.9% |
| alltime | all time | at high | -162.7% | -48.0% | -530.8% | at high | -302.9% |
NGM Biopharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $114.29 M(+698.0%) | $27.19 M(+1.2%) | $114.29 M(+28.7%) |
| Sep 2023 | - | $26.87 M(+9.3%) | $88.78 M(-8.8%) |
| Jun 2023 | - | $24.59 M(-31.0%) | $97.37 M(+71.4%) |
| Mar 2023 | - | $35.64 M(+2011.4%) | $56.82 M(+296.7%) |
| Dec 2022 | $14.32 M(-120.0%) | $1.69 M(-95.2%) | $14.32 M(-58.6%) |
| Sep 2022 | - | $35.45 M(-322.1%) | $34.56 M(-32.8%) |
| Jun 2022 | - | -$15.97 M(+133.0%) | $51.41 M(+33.0%) |
| Mar 2022 | - | -$6.85 M(-131.3%) | $38.65 M(-153.9%) |
| Dec 2021 | -$71.65 M(+40.5%) | $21.93 M(-58.1%) | -$71.65 M(-65.6%) |
| Sep 2021 | - | $52.30 M(-282.1%) | -$208.11 M(-10.2%) |
| Jun 2021 | - | -$28.72 M(-75.5%) | -$231.87 M(+18.9%) |
| Mar 2021 | - | -$117.16 M(+2.3%) | -$195.03 M(+282.4%) |
| Dec 2020 | -$51.00 M | -$114.53 M(-501.3%) | -$51.00 M(-397.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $28.54 M(+251.5%) | $17.14 M(-46.8%) |
| Jun 2020 | - | $8.12 M(-69.8%) | $32.22 M(-55.9%) |
| Mar 2020 | - | $26.87 M(-157.9%) | $73.10 M(+50.0%) |
| Dec 2019 | $48.72 M(+25.8%) | -$46.39 M(-206.3%) | $48.72 M(-50.6%) |
| Sep 2019 | - | $43.62 M(-11.0%) | $98.59 M(+44.6%) |
| Jun 2019 | - | $49.00 M(+1865.4%) | $68.20 M(+540.6%) |
| Mar 2019 | - | $2.49 M(-28.4%) | $10.65 M(-72.5%) |
| Dec 2018 | $38.73 M(-1485.2%) | $3.48 M(-73.7%) | $38.73 M(+9.9%) |
| Sep 2018 | - | $13.22 M(-254.6%) | $35.25 M(+60.0%) |
| Jun 2018 | - | -$8.55 M(-128.0%) | $22.02 M(-28.0%) |
| Mar 2018 | - | $30.58 M | $30.58 M |
| Dec 2017 | -$2.80 M(-95.7%) | - | - |
| Dec 2016 | -$64.71 M | - | - |
FAQ
- What is NGM Biopharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual CFI year-on-year change?
- What is NGM Biopharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly CFI year-on-year change?
- What is NGM Biopharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals TTM CFI year-on-year change?
What is NGM Biopharmaceuticals annual cash flow from investing activities?
The current annual CFI of NGM is $114.29 M
What is the all time high annual CFI for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual cash flow from investing activities is $114.29 M
What is NGM Biopharmaceuticals annual CFI year-on-year change?
Over the past year, NGM annual cash flow from investing activities has changed by +$99.97 M (+697.98%)
What is NGM Biopharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of NGM is $27.19 M
What is the all time high quarterly CFI for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly cash flow from investing activities is $52.30 M
What is NGM Biopharmaceuticals quarterly CFI year-on-year change?
Over the past year, NGM quarterly cash flow from investing activities has changed by -$8.45 M (-23.71%)
What is NGM Biopharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of NGM is $114.29 M
What is the all time high TTM CFI for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high TTM cash flow from investing activities is $114.29 M
What is NGM Biopharmaceuticals TTM CFI year-on-year change?
Over the past year, NGM TTM cash flow from investing activities has changed by +$57.47 M (+101.15%)